Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (P (Q73011653)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 2000

Language	Label	Description	Also known as
English	Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (P	scientific article published on 01 November 2000

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Characterization and effects of methyl-2- (4-aminophenyl)-1, 2-dihydro-1-oxo-7- (2-pyridinylmethoxy)-4-(3,4, 5-trimethoxyphenyl)-3-isoquinoline carboxylate sulfate (T-1032), a novel potent inhibitor of cGMP-binding cGMP-specific phosphodiesterase (PDE5) (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

J Kotera

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Fujishige

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

H Michibata

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Yuasa

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Kubo

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Y Nakamura

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K Omori

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

0 references

publication date

1 November 2000

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Biochemical Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

60

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1333-1341

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Nitric oxide, a novel neuronal messenger

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Nitric oxide: first in a new class of neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Guanylin: an endogenous activator of intestinal guanylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Effects of KRN2391, a novel vasodilator, on pancreatic exocrine secretion in anesthetized dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Isoenzymes of cyclic nucleotide phosphodiesterase in the human aorta: characterization and the effects of E4021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Guanosine 3':5'-cyclic monophosphate binding proteins in rat tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Occurrence of the methylisobutylxanthine-stimulated cyclic GMP binding protein in various rat tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Novel alternative splice variants of cGMP-binding cGMP-specific phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Immunohistochemical localization of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in rat tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterases.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Inhibition of cGMP breakdown promotes the induction of cerebellar long-term depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Inhibition of cyclic 3'-5'-guanosine monophosphate-specific phosphodiesterase selectively vasodilates the pulmonary circulation in chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Purification of rod outer segment GTP-binding protein subunits and cGMP phosphodiesterase by single-step column chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Potential roles of conserved amino acids in the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Purification of cGMP-binding protein phosphodiesterase from rat lung

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

C-Type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900457-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(00)00457-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11008127%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73011653&oldid=1752573693"